Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients

Thorax

Volumn 55, Issue 6, 2000, Pages 471-477

  Leckie, Margaret J ^a   Hansel, Trevor T ^a   Bryan, Shannon A ^a   Khan, Jamey ^a   Dewar, Ann ^a   Aikman, Sarah L ^a   McGrath, Jennifer ^a   Okrongly, David A ^b   Burman, John F ^a   Barnes, Peter J ^c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b BAYER CORPORATION   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Asthma; Automated method; Neutrophil activation

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; INTERLEUKIN 8; PEROXIDASE; SALBUTAMOL; TERBUTALINE;

ADULT; ARTICLE; ASTHMA; CELL SHAPE; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM; URINE LEVEL; VENOUS BLOOD;

ADULT; AGED; ASTHMA; CROSS-SECTIONAL STUDIES; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEUTROPHIL ACTIVATION;

EID: 0034082734     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.6.471     Document Type: Article

References (30)

1. 1 Kay AB, Corrigan CJ. Asthma. Eosinophils and neutrophils. Br Med Bull 1992;48:51-64.
2. 2 Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
3. 3 Martin RJ, Cicutto LC, Smith HR, et al. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991;143:351-7.
4. 4 Motojima S, Frigas E, Loegering DA, et al. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989;139:801-5.
5. 5 Fujisawa T, Terada A, Atsuta J, et al. Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma. Clin Exp Allergy 1998;28:19-25.
6. 6 Venge P, Dahl R, Peterson CG. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication. Int Arch Allergy Appl Immunol 1988;87:306-12.
7. 7 Sedgwick JB, Calhoun WJ, Vrtis RF, et al. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 1992;149:3710-8.
8. 8 Pedersen B, Dahl R, Larsen BB, et al. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 1993;48: 377-82.
9. 9 Jatakanon A, Mohammed JB, Lim S, et al. Neutrophils may contribute to the pathogenesis of airway inflammation in steroid-dependent intractable asthma. Am J Respir Crit Care Med 1998;157:A875.
10. 10 Wenzel SE, Szefler SJ, Leung CK, et al. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-43.
11. 11 Lamblin C, Gosset P, Tillie-Leblond I, et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998;157:394-402.
12. 12 Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148:713-9.
13. 13 Chanez P, Enander I, Jones I, et al. Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients. Int Arch Allergy Immunol 1996;111:83-8.
14. 14 Anticevich SZ, Hughes JM, Black JL, et al. Induction of hyperresponsiveness in human airway tissue by neutrophils: mechanism of action. Clin Exp Allergy 1996;26:549-56.
15. 15 Biasucci LM, D'Onofrio G, Liuzzo G, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996;27:611-6.
16. 16 Charuruks N, Voravud N, Sriuranpong V. MPXI and early neutrophilia: new potential therapeutic biomarkers for recombinant human granulocyte colony-stimulating factor. J Clin Lab Anal 1998;12:41-6.
17. 17 Tsakona CP, Goldstone AH. Patterns of primary degranulation as indicated by the mean myeloperoxidase index (MPXI) during bacteraemia in lymphoma transplants treated with growth factors. Clin Lab Haematol 1992;14: 273-80.
18. 18 Zipfel M, Carmine TC, Gerber C, et al. Evidence for the activation of myeloperoxidase by f-Meth-Leu-Phe prior to its release from neutrophil granulocytes. Biochem Biophys Res Commun 1997;232:209-12.
19. 19 Bizzaro N, Briani G, Boccato P. Acquired myeloperoxidase deficiency of neutrophils in a patient with aplastic anemia (idiopathic marrow aplasia). Acta Haematol 1988;80:71-3.
20. 20 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1986;136:225-44.
21. 21 Saunders AM. Development of automation of differential leukocyte counts by use of cytochemistry. Clin Chem 1972; 18:783-8.
22. 22 Simson E, Groner W. The state of the art for the automated WBC differential. Part 1: Analytical performance. Lab Hematol 1994;1:13-22.
23. 23 Cole AT, Garlick NM, Galvin AM, et al. A flow cytometric method to measure shape change of human neutrophils. Clin Sci (Colch) 1995;89:549-54.
24. 24 Keller HU, Fedier A, Rohner R. Relationship between light scattering in flow cytometry and changes in shape, volume, and actin polymerization in human polymorphonuclear leukocytes. J Leukoc Biol 1995;58:519-25.
25. 25 Sabroe I, Hartnell A, Jopling LA, et al. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol 1999;162:2946-55.
26. 26 Vowells SJ, Sekhsaria S, Malech HL, et al. Flow cytometry analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 1995;178: 89-97.
27. 27 Berends C, Hoekstra MO, Dijkhuizen B, et al. Expression of CD35(CR1) and CD11b(CR3) on circulating neutrophils and eosinophils from allergic asthmatic children. Clin Exp Allergy 1993;23:926-33.
28. 28 Lerche A, Bisgaard H, Christensen JD, et al. Lactoferrin, myeloperoxidase, lysozyme and eosinophil cationic protein in exudate in delayed type hypersensitivity. Allergy 1988;43: 139-45.
29. 29 Teran LM, Campos MG, Begishvilli BT, et al. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients. Clin Exp Allergy 1997;27:396-405.
30. 30 Shute JK, Vrugt B, Lindley IJ, et al. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997;155:1877-83.